Best Medicines Coalition / Coalition pour de meilleurs médicaments
Registration:
22
of
54
(2020-03-30
to
2020-04-01)
Legislative Proposal, Bill or Resolution
- Provide feedback on Bill C-213, the Canada Pharmacare Act.
- Share patient groups perspectives on national pharmacare proposals (follow-up from the Health Committee's report and the ongoing work of the Advisory Council on the Implementation of National Pharmacare)
Policies or Program
- Ensure patient organizations are consulted during the proposed creation of the Canadian Drug Agency as outlined in Budget 2019.
- Provide feedback on Budget 2019's proposal for a national strategy for high-cost drugs for rare diseases.
- Provide feedback on the Government of Canada's response to COVID-19 to address the potential exacerbation of drug shortages.
Policies or Program, Regulation
- Meet with federal officials to discuss Canada's response to the proposed bulk importation of medications from Canada to the United States.
- Share patient groups perspectives on drug pricing issues, specifically regulations and guidelines related to the Patented Medicine Prices Review Board.
Regulation
- Feedback on "Fit for Purpose: Findings and Recommendations of the External Review of the Pan-Canadian Health Organizations - Summary Report"
- Request to delay implementation of the federal PMPRB regulations in light of the COVID-19 pandemic allowing all stakeholders to focus efforts on dealing with the public health emergency.